BioScrip buys CarePoint Partners

BioScrip has agreed to acquire CarePoint Partners for $223 million, bringing together two of the major national players in home infusion therapy, according to a press release.

The deal will also see BioScrip reap an estimated $45 million future tax benefit as a result of the transaction. CarePoint Partners, founded in 2008 in Cincinnati, services 20,500 patients annually, has 28 sites of service in nine states, and is expected to generate approximately $160 million in annual revenue, the release noted.

“This transaction is a significant milestone for BioScrip,” stated Rick Smith, president and CEO. “It meets our stated goal of expanding our infusion business through strategic acquisitions to build scale in a highly fragmented industry.” The deal, which is subject to certain adjustments, is expected to close in the third quarter of 2013.

DME Billing Service
Provider of Professional
DME Billing Services

DME Billing News Feed:


Retrieved From: